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Abstract The highly conserved DNA-binding protein pUL56 of
human cytomegalovirus (HCMV) was found to be predominantly
localized throughout the nucleus as well as in viral replication
centers of infected cells. The latter localization was abolished by
phosphono acetic acid, an inhibitor of viral DNA replication.
Immunofluorescence revealed that pUL56 co-localized in repli-
cation centers alongside pUL112^113 and pUL44 at late times of
infection. By co-immunoprecipitations, a direct interaction with
pUL44, a protein of the replication fork, was detected. These
results showed for the first time that HCMV pUL56 is localized
in viral replication centers, implicating that DNA replication is
coupled with packaging.
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1. Introduction
Recently, we demonstrated that the human cytomegalovirus
(HCMV) UL56 gene product [6], the homolog of the herpes
simplex virus 1 (HSV-1) UL28 gene product, binds to HCMV
DNA packaging motifs and cleaves DNA bearing these motifs
[4,5]. These results are in line with studies on homologous
proteins of HSV-1 ICP18.5 (pUL28) and pseudorabies virus
showing by use of viral mutants that the deletion of UL28
leads to nuclear accumulation of naked nucleocapsids and
uncleaved concatemeric DNA [1,15,19]. This observation led
us to the assumption that pUL56 plays a key role in DNA
packaging, and may functionally resemble a terminase sub-
unit. This is consistent with previous genetic analysis which
demonstrated that a new class of anti-HCMV agents inhibit
HCMV DNA maturation by direct interaction with the viral
UL89 [13] and UL56 [20] gene products.
It is known that herpes viral transcription, DNA synthesis
and packaging occur in de¢ned intranuclear globular struc-
tures called replication centers [8,9]. Previously, Ahn and
Hayward [2] reported that formation of viral DNA replication
compartments in HCMV-infected cells is initiated within
granular structures that bud from the periphery of some of
the promyelocytic leukemia protein oncogenic domains
(PODs) and subsequently merge into larger structures that
are £anked by PODs.
In this study, experiments are described regarding the local-
ization of HCMV pUL56 in viral replication centers, the co-
localization with two proteins, pUL112^113 and pUL44,
known to be involved in DNA replication, and a direct phys-
ical interaction regarding pUL44. The work presented here is
the ¢rst incidence for herpes viruses that such an association
takes place.
2. Materials and methods
2.1. Cells and viruses
Human foreskin ¢broblasts (HFF) were grown in Dulbecco’s me-
dium supplemented with 10% fetal calf serum, 2 mM glutamine and
penicillin (5 U/ml) and streptomycin (50 Wg/ml) as described previ-
ously. Preparation of HCMV AD169 and infection of HFF at a
multiplicity of infection (moi) of 1.0 was carried out as described
before [7].
2.2. Transient DNA expression
For DNA transfection experiments, COS-7 cells were seeded on 60
mm diameter petri dishes with glass coverslips. DNA (10 Wg/well) was
introduced for transient expression assays in 60% con£uent cells using
the lipofectin reagent (Life Technologies) as recommended by the
manufacturer. Analysis was carried out at 40 h post transfection
(p.t.) by indirect immuno£uorescence.
2.3. Puri¢cation of the pUL56 antiserum
A⁄nity puri¢cation of the anti-UL56 antibody was done as follows.
A L-galactosidase fusion protein, fusproII, containing a hydrophilic
amino acid stretch from amino acid 324 to 524 of pUL56 was coupled
to activated immunoa⁄nity supports A⁄-Gel 10 and A⁄-Gel 15 (1:2
A⁄-Gel 10/A⁄-Gel 15; Bio-Rad Laboratories) as described by Bio-
Rad, yielding A⁄-Gel 10/15-pUL56. Unspeci¢c binding sites were
blocked by incubation with bu¡er b (1 M ethanolamine^HCl pH
8.0, 0.02% NaN3) for 1 h. The resin was equilibrated with start bu¡er
(150 mM NaCl, 50 mM Tris^HCl pH 8.0, 0.02% NaN3). High titer
human convalescent serum was incubated overnight with the prepared
a⁄nity matrix. After the matrix was washed twice with 10 bed vol-
umes of ice-cold start bu¡er, the bound antibody was eluted in 200
mM glycine^HCl (pH 2.5). The puri¢ed anti-pUL56 antibody, pab-
UL56, was neutralized with 100 mM Tris^HCl (pH 8.0). The speci¢c-
ity of the antibody was tested in Western blots (as shown in [6]).
2.4. Immuno£uorescence and Immunoprecipitation
For immuno£uorescence, cells were grown on glass coverslips. At
various times post infection (p.i.)/p.t., coverslip cultures were ¢xed in
3% paraformaldehyde as described previously [18].
Detection of HCMV pUL56 was carried out with pabUL56 [5,6]
for 45 min at room temperature prior to further incubation for 45 min
with £uorescein-labeled goat anti-human F(abP)2 fragments. For dou-
ble staining, HCMV pUL56-speci¢c human pabUL56 and monoclo-
nal antibody (mAb) M23, against the gene products of HCMV
pUL112^113 (provided by K. Hirai, Tokyo, Japan), or pUL44-spe-
ci¢c antibody RG#1202 (Rumbaugh-Goodwin Institute for Cancer
Research), or IE1/2-speci¢c mAb (NEA9221 from NEN) was used
in the ¢rst incubation. In the second incubation, £uorescein-labeled
anti-human and Texas red-labeled anti-mouse F(abP)2 fragments were
used.
For immunoprecipitation, total cell extracts were prepared from
[35S]methionine-labeled cultures by solubilization in co-immunopreci-
pitation bu¡er (20 mM Tris^HCl pH 7.5, 100 mM NaCl, 1% NP-40,
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5 mM EDTA, 25 mM iodoacetamide, 0.4% Na-deoxycholate, 1 mM
PMSF, 100 U/ml Trasylol) and ultrasonic treatment. Insoluble mate-
rial was sedimented for 30 min at 100 000Ug. Comparable amounts of
extracts and pUL56- (1:20), pUL44-speci¢c antibody (1:200) or mAb
27-156 against glycoprotein B (1:10) were used for precipitation as
described previously [7].
2.5. Western blot and autoradiography
The supernatants or precipitated proteins were electrophoresed on
8% polyacrylamide gels, transferred to nitrocellulose sheets and sub-
jected to Western blot analysis as described previously [6]. The anti-
body RG#1202 (1:4000 in 3% bovine serum albumin (BSA)) speci¢c
for pUL44 (p52) was used as the primary antibody prior to incubation
with horseradish peroxidase-conjugated anti-mouse F(abP)2 fragments
(1:300 in 3% BSA). After immunostaining, radioactive blots were
subjected to autoradiography.
3. Results
3.1. Localization of HCMV pUL56 in viral replication centers
In order to precisely examine intracellular distribution of
HCMV pUL56, immuno£uorescence using pabUL56 [6],
which was puri¢ed from high titer human serum by column
a⁄nity chromatography (A⁄-Gel 10/15-pUL56), was per-
formed. Coverslip HFF cultures were mock-infected or in-
fected with HCMV (moi of 1) for 12, 24, 48 and 72 h prior
to immuno£uorescence. In HCMV-infected cells, pabUL56
detected antigen predominantly in the nucleus (Fig. 1A). Dis-
tribution and intensity of £uorescence changed during the
course of infection: at 12 h p.i., weak and more homogeneous
nuclear staining was observed, that increased with time until
late time after infection when in addition to homogeneous
nuclear staining bright intranuclear patches were detected.
Fluorescence staining presumably in the nucleolar region
was also detected only early after infection (Fig. 1A, a, b),
but was no longer seen at later times p.i. In uninfected cells,
no £uorescence was detected (Fig. 1A, e). To determine
whether nuclear translocation of pUL56 was an early or late
event, cells were infected in the presence of 200 Wg/ml phos-
phono acetic acid (PAA) and analyzed at 72 h p.i. by double
staining with monospeci¢c pabUL56 and mAb against the
HCMV IE1/2 protein. IE1/2 antigen was restricted to the
nucleus, as expected. The pUL56 £uorescence pattern of
PAA-treated cells equaled that of untreated cells at 24 h p.i.
(Fig. 1B, a). This observation suggested that viral DNA rep-
lication is required for translocation of pUL56 into intranu-
clear patches but not for its expression.
3.2. Co-localization of HCMV pUL56 with the gene products
of open reading frame (ORF) UL112^113
Double staining of infected cells was performed to deter-
mine whether compartmentalization of pUL56 to nuclear rep-
lication centers late p.i. was comparable to that of gene prod-
ucts of the ORF UL112^113 [12], which encode four proteins
that are required for DNA replication. In infected cells,
Fig. 1. Analysis of intranuclear distribution of HCMV pUL56. (A)
HFF cells were mock-infected (e) or infected with HCMV for 12
(a), 24 (b), 48 (c) and 72 h (d) and subjected to immuno£uorescence
with antibody against pUL56, pabUL56. (B) HFF cells infected
with HCMV in the presence of PAA were double-stained with anti-
bodies against pUL56 (a) and against IE1/2 (aP) at 72 h p.i., respec-
tively.
Fig. 2. Co-localization of pUL56 with HCMV gene products of
ORF UL112^113. (A) HFF mock-infected (f) or infected with
HCMV were double-stained with pabUL56 and mAb M23 against
pUL112^113 at 12 (a), 24 (b), 48 (c) and 72 h (d) p.i. HFF infected
with HCMV in the presence of PAA were double-stained with pab-
UL56 and mAb M23 against ORF UL112^113 at 72 h p.i. (e). A
merge of the FITC and Texas red-stained cells is shown in addition
(a3^f3). (B) COS-7 cells were transfected with vector (b) or co-trans-
fected with UL56 and the 43K form of ORF UL112^113. Double
staining with pabUL56 (a1, b1) and mAb M23 (a2, b2) was per-
formed at 40 h after transfection. A merge of the FITC and Texas
red-stained cells is shown in addition (a3^f3).
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pUL56-speci¢c immuno£uorescence of intranuclear replica-
tion centers at 48 and 72 h p.i. indeed partially co-localized
with that of pUL112^113 (Fig. 2A, c, d). Infection in the
presence of PAA on the other hand revealed a punctate stain-
ing for pUL112^113 while pUL56 again was homogeneously
distributed with some accumulation presumably in nucleoli
(Fig. 2A, e).
To determine whether the gene product of ORF UL112^
113 is able to translocate pUL56 into replication centers, im-
muno£uorescence after transient transfection of pUL56 and
the 43K form of UL112^113, which is the predominant prod-
uct in infected cells [12], was performed. While pUL112^113
was detected in prereplication centers [8], pUL56 showed a
homogeneous nuclear staining (Fig. 2B). This result suggested
that translocation of pUL56 in replication centers in infected
cells is independent of interaction with pUL112^113.
3.3. Co-localization of HCMV pUL56 with HCMV pUL44
In order to identify an interaction with an additional pro-
tein known to be involved in DNA replication, immuno£uo-
rescence and immunoprecipitation using mAb against pUL44
was undertaken. Early after infection for both proteins homo-
geneous nuclear staining was observed (Fig. 3A, a, b), and
both products were also found in presumably nucleolar re-
gions. This distribution changed after 48 h p.i. to a distinct
staining of replication centers (Fig. 3A, c). However, in con-
trast to the pUL56 £uorescence pattern, the nucleolar accu-
mulation of pUL44 seemed to be preserved. The £uorescence
pattern in the presence of PAA was for both proteins similar
to that seen at early times after infection (Fig. 3A, e). Again,
mock-infected HFF revealed no speci¢c immuno£uorescence
signals (Fig. 3A, f).
To examine a putative interaction between both proteins,
co-immunoprecipitation prior to Western blot analysis and
autoradiography was performed. Autoradiographic analysis
of the blotted precipitation with pabUL56 detected pUL56
and in addition a 50 kDa protein (Fig. 3B, lane 2). On the
other hand, using antibody against pUL44 for immunopreci-
pitation, a protein of about 130 kDa was detected in the
precipitates, in addition (Fig. 3B, lane 4). Additional co-pre-
cipitating proteins could represent the approximately 100 kDa
precursor (expected molecular weight) of pUL56, which is not
seen in urea gels as well as in virions, while the 65 kDa band
might be pp65, which adheres to protein A Sepharose. Co-
immunoprecipitation with an antibody against HCMV gB,
mAb 27-156, recognized only gB-speci¢c gene products (Fig.
3B, lane 6). Identical co-immunoprecipitates as well as cell
extracts of mock- and HCMV-infected HFF were subjected
to Western blot analysis using pUL44-speci¢c mAb
RG#1202. pUL44 was detected in all immunocomplexes
(Fig. 3C, 2, 4) as well as HCMV-infected cell extracts (Fig.
3C, 8). No detection was observed in control co-immunopre-
cipitates with mAb against HCMV gB (Fig. 3C, 6). These
experiments showed that the co-precipitated 50 kDa protein
indeed was pUL44 and implicates a direct interaction between
HCMV pUL56 and pUL44.
Fig. 3. Co-localization of pUL56 with HCMV pUL44. (A) HFF
mock-infected (f) or infected with HCMV were double-stained with
pabUL56 and mAb RG#1202 against pUL44 at 12 (a), 24 (b), 48
(c) and 72 h (d) p.i. HFF infected with HCMV in the presence of
PAA were double-stained with pabUL56 and mAb RG#1202
against pUL44 at 72 h p.i. (e). (B) Mock-infected (1, 3, 5) or
HCMV-infected (2, 4, 6) HFF at 72 h p.i. were co-immunoprecipi-
tated with pabUL56 (1, 2), mAb RG#1202 (3, 4) or anti-gB mAb
27-156 (5, 6) and subjected to SDS^PAGE prior to transfer onto ni-
trocellulose and autoradiographic analysis. (C) The identical immu-
noprecipitates of mock-infected (1, 3, 5) or HCMV-infected (2, 4, 6)
HFF together with extracts of mock- (7) and HCMV-infected cells
(8) were subjected to immunoblot analysis using antibody
RG#1202. The arrows indicate the position of pUL56, pUL44 and
gB, the molecular weight markers (MW) are indicated on the left.
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4. Discussion
The results presented are to our knowledge the ¢rst evi-
dence that the highly conserved structural protein pUL56 of
HCMV is associated with viral replication centers. Currently,
no reports are available about similar associations of pUL56
homologs of other herpes viruses. In infected cells, pUL56
accumulates in discrete regions of the nucleus. Studies in the
presence of PAA demonstrated that this intranuclear localiza-
tion was dependent of viral DNA replication.
Interestingly, pUL56 was partially co-localized with the
gene product of ORF UL112^113. Pari and Anders [16] re-
ported that this ORF encodes four proteins, which are trans-
lated from di¡erentially spliced transcripts and are required
for HCMV DNA replication in transient complementation
assays. In addition, Yamamoto et al. [22] showed by use of
antisense strategy that UL112^113 gene products as well as
viral DNA replication were concomitantly a¡ected. It was
previously reported that UL112^113 products form prerepli-
cation structures, and redistribute during viral DNA replica-
tion to replication compartments [3]. This report is in line
with our observation that after solitary expression the 43K
form of UL112^113 is localized in prereplication structures.
Regarding pUL56, our results showed that its translocation
into viral replication centers is independent of pUL112^113.
Remarkably, we observed co-localization as well as co-precip-
itation of pUL56 with pUL44, a protein known to be pre-
dominantly localized in intranuclear viral replication centers
and to increase DNA-binding speci¢city of the viral DNA
polymerase [10,17,21]. At present, it is not possible to clearly
distinguish between HCMV DNA replication, cleavage and
packaging (for review, [2]). Our observation of the direct in-
teraction between the structural protein pUL56 and the non-
structural protein pUL44 is therefore intriguing and needs
further elucidation.
Regarding our previous ¢ndings of pUL56 DNA-binding
and cleavage [4,5], localization in replication centers is in
line with this function. One may speculate that DNA-binding
of pUL56 occurs concomitant and/or consecutive to viral
DNA synthesis, DNA^protein complexes are then translo-
cated to empty capsids where the protein remains attached
after packaging. Interestingly, DNA of ssDNA phage
qX174 is packaged into a procapsid by a unique mechanism
in that this process is coupled with DNA replication [11].
Further, Lamberti and Weller ([14]) reported that at 6 and
8 h p.i., HSV capsids co-localize with the major DNA-binding
protein in replication compartments suggesting that cleavage
and packaging occur at this site. This ¢nding implicates that
DNA replication could be coupled with packaging also in the
case of herpes viruses. This mechanism could explain our ob-
servations and future experiments will show whether this no-
tion indeed re£ects the processes in infected cells.
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